135 related articles for article (PubMed ID: 31867768)
1. Preclinical safety evaluation of ET-26 hydrochloride, a novel intravenous anesthetic agent, in beagle dogs.
Zhang Y; Deng C; Gong D; Kang Y; Liu J; Zhang W
J Appl Toxicol; 2020 May; 40(5):679-690. PubMed ID: 31867768
[TBL] [Abstract][Full Text] [Related]
2. An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in Rats.
Wang B; Yang J; Chen J; Kang Y; Yang LH; Liu J; Zhang WS
Anesth Analg; 2017 Aug; 125(2):442-450. PubMed ID: 28514325
[TBL] [Abstract][Full Text] [Related]
3. Non-clinical single- and repeated-dose toxicity studies of ET-26 hydrochloride in rats.
Zhang Y; Zhang Y; Deng C; Gong D; Kang Y; Liu J; Zhang W
J Appl Toxicol; 2020 Aug; 40(8):1099-1112. PubMed ID: 32170788
[TBL] [Abstract][Full Text] [Related]
4. The preclinical pharmacological study of a novel intravenous anesthetic, ET-26 hydrochloride, in aged rats.
Chang P; Su Y; Gong D; Kang Y; Liu J; Zhang Y; Zhang WS
PeerJ; 2022; 10():e13995. PubMed ID: 36196398
[TBL] [Abstract][Full Text] [Related]
5. Safety Pharmacology Study of ET-26 Hydrochloride, a Potential Drug for Intravenous General Anesthesia, in Rats and Beagle Dogs.
Zhang Y; Jiang Y; Chang P; Kang Y; Gong D; Liu J; Zhang W
Front Pharmacol; 2021; 12():679381. PubMed ID: 34135759
[No Abstract] [Full Text] [Related]
6. ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats.
Wang B; Chen S; Yang J; Yang L; Liu J; Zhang W
PLoS One; 2017; 12(8):e0183439. PubMed ID: 28813523
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Pharmacokinetics Study of a Novel Intravenous Anesthetic ET-26 Hydrochloride.
Zhang YJ; Deng C; Yang J; Gong D; Kang Y; Liu J; Zhang W
Curr Drug Metab; 2019; 20(13):1073-1081. PubMed ID: 31870260
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsis.
Wang B; Jiang J; Yang J; Chen J; Zhu Z; Liu J; Zhang W
Eur J Pharm Sci; 2017 Nov; 109():441-445. PubMed ID: 28882766
[TBL] [Abstract][Full Text] [Related]
9. Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.
Campagna JA; Pojasek K; Grayzel D; Randle J; Raines DE
Anesthesiology; 2014 Dec; 121(6):1203-16. PubMed ID: 25170571
[TBL] [Abstract][Full Text] [Related]
10. Safety and toxicology assessment of sodium nitrite administered by intramuscular injection.
Miller L; Hébert CD; Grimes SD; Toomey JS; Oh JY; Rose JJ; Patel RP
Toxicol Appl Pharmacol; 2021 Oct; 429():115702. PubMed ID: 34464673
[TBL] [Abstract][Full Text] [Related]
11. Safety and clinical effect of i.v. infusion of cyclopropyl-methoxycarbonyl etomidate (ABP-700), a soft analogue of etomidate, in healthy subjects.
Valk BI; Absalom AR; Meyer P; Meier S; den Daas I; van Amsterdam K; Campagna JA; Sweeney SP; Struys MMRF
Br J Anaesth; 2018 Jun; 120(6):1401-1411. PubMed ID: 29793605
[TBL] [Abstract][Full Text] [Related]
12. Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogs.
Yang J; Kang Y; Wang B; Yang L; Liu J; Zhang W
Eur J Pharm Sci; 2017 Mar; 99():343-349. PubMed ID: 28057551
[TBL] [Abstract][Full Text] [Related]
13. The fentanyl/etomidate-anesthetized beagle (FEAB) model in safety pharmacology assessment.
van der Linde HJ; Deuren BV; Somers Y; Teisman A; Gallacher DJ
Curr Protoc Pharmacol; 2011 Sep; Chapter 10():Unit10.13. PubMed ID: 21898330
[TBL] [Abstract][Full Text] [Related]
14. The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research.
Van Deuren B; Van Ammel K; Somers Y; Cools F; Straetemans R; van der Linde HJ; Gallacher DJ
J Pharmacol Toxicol Methods; 2009; 60(1):11-23. PubMed ID: 19422925
[TBL] [Abstract][Full Text] [Related]
15. EEG in the FEAB model: measurement of electroencephalographical burst suppression and seizure liability in safety pharmacology.
van der Linde HJ; Van Deuren B; Somers Y; Teisman A; Drinkenburg WH; Gallacher DJ
J Pharmacol Toxicol Methods; 2011; 63(1):96-101. PubMed ID: 20601023
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and Toxicokinetics of a Four-Week Repeated Gavage of Levamisole in Male Beagle Dogs: A Good Laboratory Practice Study.
Zhang J; Wang J; Chen L; Yu X; Zhang S; Yu Y
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38276014
[TBL] [Abstract][Full Text] [Related]
17. Safety Evaluation of Sevoflurane as Anesthetic Agent in Mouse Model of Myocardial Ischemic Infarction.
Cheng X; Hou J; Liu J; Sun X; Sheng Q; Han P; Kang YJ
Cardiovasc Toxicol; 2017 Apr; 17(2):150-156. PubMed ID: 27048291
[TBL] [Abstract][Full Text] [Related]
18. Novel etomidate derivatives.
Sneyd JR
Curr Pharm Des; 2012; 18(38):6253-6. PubMed ID: 22762475
[TBL] [Abstract][Full Text] [Related]
19. Etomidate adversely alters determinants of left ventricular afterload in dogs with dilated cardiomyopathy.
Pagel PS; Hettrick DA; Kersten JR; Tessmer JP; Lowe D; Warltier DC
Anesth Analg; 1998 May; 86(5):932-8. PubMed ID: 9585271
[TBL] [Abstract][Full Text] [Related]
20. A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function.
Xu X; Wei Y; Dong Y; Qiu Y; Mei Z; Wang K; Xiu J; Wang T; Zeng L; Dong X; Shen Y; Jiang W; Li Q
J Pharmacol Exp Ther; 2021 Dec; 379(3):324-330. PubMed ID: 34521699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
